Abstract:Introduction: Phosphoinositide-specific phospholipases C-gamma 1 (PLC-gamma 1) signaling has been shown to modulate osteoarthritis (OA) chondrocyte metabolism. However, the role of PLC-gamma 1 in OA osteoblasts remains unclear. Herein, whether and how PLC-gamma 1 was involved in mineralization in OA subchondral bone osteoblasts were investigated. Methods: Primary non-OA and OA osteoblasts of human and rat isolated from the subchondral bone or the calvaria were cultured in vitro, as well as mouse pre-osteoblastic cell line MC3T3-E1 cells. Rat knee OA model was induced by anterior cruciate ligament transection (ACLT), in which bone canal was carried out from the surface of lateral epicondyle of femur using micro-electric drill. Morphological characteristics of subchondral bone structure and articular cartilage were assessed using CT, micro-CT, and Safranin O/Fast green staining, respectively. Mineralization was measured by alizarin red staining. The expression and production of genes involved in osteoblastic phenotype and mineralization were evaluated by qPCR, western blotting, and immunohistochemistry assays, respectively. The inhibitions were performed using inhibitors and ShRNAs. Results: The decreased relative bone density and thickness in the early stage of OA and the increased one in the late stage of OA were observed in subchondral bone of ACLT-rat model. Decreased ALP and OCN levels and absorbance values of ARS content were observed in in vitro osteoblasts isolated from 2 w post-ACLT rat model, as well as IL-1 beta-treated (for maintaining and mimicking inflammatory status) human OA and rat osteoblasts. Decreased Atg7 level and LC3BII/I ratio in combination with an increase in the P62 level, was concomitant with decreased ALP and OCN mRNA levels and absorbance values of ARS content in OA or IL-1 beta-treated osteoblasts. Specific inhibition of PLC-gamma 1 by ShRNAs or inhibitor (U73122) elevated ALP and OCN mRNA levels and absorbance values of ARS content accompanied with increased Atg7 level and LC3BII/I ratio in combination with a decrease in the P62 level in OA osteoblasts. Furthermore, the promoting effect of PLC-gamma 1 inhibition on ALP and OCN mRNA levels and absorbance values of ARS content was reversed by endoplasmic reticulum (ER) stress activator HA15, as well as autophagic inhibitors CQ and 3MA. Injection with PLC-gamma 1 inhibitor U73122 from the surface of lateral epicondyle of femur reduced aberrant subchondral bone formation and attenuated articular cartilage degeneration in ACLT-rat. Conclusion: Aberrant changes of OA subchondral bone structure were concomitant with altered osteoblastic phenotype and mineralization. Impaired autophagy contributed to decreased osteoblastic mineralization in the early stage of OA. PLC-gamma 1 inhibition promoted osteoblastic mineralization through increasing autophagy in OA osteoblasts, which was partially attributed to suppression of ER stress. Targeting PLC-gamma 1 in subchondral bone osteoblasts could be more efficacious for OA therapy through treating the bone and cartilage at the same time. In summary, we hypothesize that suppressing PLC gamma 1 promotes mineralization of osteoarthritic subchondral bone osteoblasts via increasing autophagy, thereby ameliorating articular cartilage degeneration.

Noggin Inhibits IL-1β and BMP-2 Expression, and Attenuates Cartilage Degeneration and Subchondral Bone Destruction in Experimental Osteoarthritis

Reciprocal Inhibition of YAP/TAZ and NF-κB Regulates Osteoarthritic Cartilage Degradation

Nesfatin-1 suppresses interleukin-1 beta-induced inflammation, apoptosis, and cartilage matrix destruction in chondrocytes and ameliorates osteoarthritis in rats

Specnuezhenide Decreases Interleukin-1β-Induced Inflammation in Rat Chondrocytes and Reduces Joint Destruction in Osteoarthritic Rats.

The pro-inflammatory effect of NR4A3 in osteoarthritis

Suppressing Phosphoinositide-Specific Phospholipases Cγ1 Promotes Mineralization of Osteoarthritic Subchondral Bone Osteoblasts Via Increasing Autophagy, Thereby Ameliorating Articular Cartilage Degeneration

Nootkatone Protects Cartilage Against Degeneration in Mice by Inhibiting NF-κB Signaling Pathway

Cartilage stem/progenitor cells are activated in osteoarthritis via interleukin-1β/nerve growth factor signaling.

Nerve Growth Factor Receptor Limits Inflammation to Promote Remodeling and Repair of Osteoarthritic Joints

Interleukin‑Iβ Promotes Cartilage Degeneration by Regulating Forkhead Box Protein O4 and Type Ⅱ Collagen.

Necrostatin-1 Attenuates Trauma-Induced Mouse Osteoarthritis and IL-1β Induced Apoptosis Via HMGB1/TLR4/SDF-1 in Primary Mouse Chondrocytes.

IL-1β Receptor Antagonist (Il-1Ra) Combined with Autophagy Inducer (Tat-Beclin1) is an Effective Alternative for Attenuating Extracellular Matrix Degradation in Rat and Human Osteoarthritis Chondrocytes

PLCγ1 Inhibition Combined with Inhibition of Apoptosis and Necroptosis Increases Cartilage Matrix Synthesis in IL‐1β‐treated Rat Chondrocytes

The Mir-302C/transforming Growth Factor-Β Receptor Type-2 Axis Modulates Interleukin-1Β-induced Degenerative Changes in Osteoarthritic Chondrocytes

Nesfatin-1 suppresses interleukin-1β-induced inflammation, apoptosis, and cartilage matrix destruction in chondrocytes and ameliorates osteoarthritis in rats

The Role of the Bone Morphogenetic Protein Antagonist Noggin in Nucleus Pulposus Intervertebral Disc Cells

Notch signaling in chondrocytes modulates endochondral ossification and osteoarthritis development

The Nrf2/HMGB1/NF-κB axis modulates chondrocyte apoptosis and extracellular matrix degradation in osteoarthritis

Down-regulation of MiR-138-5p Protects Chondrocytes ATDC5 and CHON-001 from IL-1 Β-Induced Inflammation Via Up-regulating SOX9.

LncRNA NKILA attenuates the progression of osteoarthritis through the targeted inhibition of the NF-κB pathway

NOV/CCN3 induces cartilage protection by inhibiting PI3K/AKT/mTOR pathway